Poorly controlled gout: who is doing poorly?
10.11622/smedj.2016129
- Author:
Faith Li-Ann CHIA
- Publication Type:Journal Article
- Keywords:
allopurinol;
drug hypersensitivity;
hyperuricaemia;
medication adherence
- MeSH:
Allopurinol;
therapeutic use;
Arthritis;
therapy;
Comorbidity;
Gout;
drug therapy;
Humans;
Hyperuricemia;
drug therapy;
Inflammation;
Medication Adherence;
Patient Education as Topic;
Primary Health Care;
Professional-Patient Relations;
Rheumatology;
methods;
Singapore;
Uric Acid;
therapeutic use
- From:Singapore medical journal
2016;57(8):412-414
- CountrySingapore
- Language:English
-
Abstract:
Gout, an inflammatory arthritis caused by the deposition of monosodium urate crystals, is commonly seen in primary care and specialist clinics. In recent years, there has been a resurgence of interest in gout due to advances in therapies and the understanding of pathophysiology, with new guidelines being published by international bodies. However, there is still a gap between the goals of treatment and actual day-to-day practice. Barriers that result in poorly controlled gout include patient factors such as lack of understanding of the disease, stigma and nonadherence to treatment, as well as physician factors such as knowledge gaps, inadequate use of allopurinol and lack of ownership of the disease. The medical profession needs to do more to bridge the gap through physician and patient education, identification of treatment targets with appropriate use of drugs, and dissemination of guidelines.
